(Q38420631)

2 September 2017

1 reference

title

Ranolazine for the treatment of atrial fibrillation (English)

1 reference

2 September 2017

1 reference

Gian Marco Rosa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ulrico Dorighi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Michele Brunacci

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Giovanni Bertero

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

15 April 2015

1 reference

Expert Opinion on Investigational Drugs

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

825-836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Amiodarone versus sotalol for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Novel pharmacological targets for the rhythm control management of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Electrophysiologic basis for the antiarrhythmic actions of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

The role of the funny current in pacemaker activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Emergency management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Atrial fibrillation. DIONYSOS study comparing dronedarone with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

New developments in atrial antiarrhythmic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Clinical efficacy of amiodarone as an antiarrhythmic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

Pharmacokinetic evaluation of desogestrel as a female contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

The historical development, cellular electrophysiology and pharmacology of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2015.1036984

10.1517/13543784.2015.1036984

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25872749%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference